ZIOPHARM ONCOLOGY INC
Profile
Company Names
ZIOPHARM ONCOLOGY INC
Addresses
ONE FIRST AVENUE, PARRIS BUILDING 34, NAVY YARD PLAZA, BOSTON, MA 02129
ONE FIRST AVENUE, PARRIS BLDG 34, NAVY YARD PLAZA, BOSTON, MA 02129
1180 AVENUE OF THE AMERICA, 19TH FLOOR, NEW YORK, NY 10036
Phone Numbers
617-259-1970
646-214-0700
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$368,830,309.00
Number of Funding Rounds:
8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2019-09-12
$19,515,153.00
$19,515,153.00
$0.00
7
2019-07-26
$105,106,064.00
$105,106,064.00
$0.00
6
2018-11-13
$50,000,000.00
$107,007,575.00
$57,007,575.00
Equity
5
2016-06-30
$120,000,000.00
$120,000,000.00
$0.00
Equity
4
2015-01-13
$57,500,000.00
$57,500,000.00
$0.00
Equity
3
2012-11-07
$3,637.00
$3,637.00
$0.00
Equity
2
2011-01-12
$11,645,928.00
$11,645,928.00
$0.00
Equity
1
2009-09-15
$5,059,527.00
$5,059,527.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT
BRAUNSTEIN
DIRECTOR
JAMES
CANNON
DIRECTOR
ROBERT
HADFIELD
EXECUTIVE OFFICER
RANDAL
J.
KIRK
DIRECTOR
JONATHAN
LEWIS
EXECUTIVE OFFICER, DIRECTOR
ZIOPHARM ONCOLOGY INC
| EVERYONE COUNTS, INC.
| MASON CAPITAL LTD
| SAMSON EMET MUNICIPAL REAL ESTATE STRATEGY LP
| ABSOLUTE RETURN MULTI-STRATEGY I LP
| TAX EFFICIENT INFLATION PROTECTION STRATEGY LLC SER D
| GLOBAL DIVERSIFIED LENDING FUND, L.P.
| INTERNATIONAL EQUITY LONG-ONLY FUND LP - SERIES E
| FIERA CAPITAL AGRICULTURE FUND
| JLJ FIXED DIVIDEND REIT LLC
DAVID
MAUNEY
EXECUTIVE OFFICER
TIMOTHY
MCINERNEY
DIRECTOR
SCOTT
TARRIFF
DIRECTOR
MICHAEL
WEISER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-11-13
D
BIOTECHNOLOGY
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
DECLINE TO DISCLOSE
Equity
2016-06-30
D
BIOTECHNOLOGY
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
DECLINE TO DISCLOSE
Equity
2015-01-13
D
PHARMACEUTICALS
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
DECLINE TO DISCLOSE
Equity
2012-11-07
D
PHARMACEUTICALS
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
NO REVENUES
Equity
2011-01-12
D
PHARMACEUTICALS
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
NO REVENUES
Equity
2009-09-15
